Giant prolactinoma in Asian-Indians: A single-center experience from Western India

Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas

(2022) H. Hacisahinogullari et al.   JOURNAL FRANCAIS D OPHTALMOLOGIE

Giant prolactinoma in children and adolescents: a single-center experience and systematic review

(2022) Sandeep Kumar et al.   Pituitary

Comparison of the effects of medical and surgical treatments in giant prolactinoma: a single-center experience

(2021) Soner Cander et al.   Hormones-International Journal of Endocrinology and Metabolism

Management of prolactinomas in children and adolescents; which factors define the response to treatment?

(2021) Ayfer Alikasifoglu et al.   Pituitary

Epidemiology of overweight and obesity in Indian adults - A secondary data analysis of the National Family Health Surveys

(2021) Madhur Verma et al.   Diabetes & Metabolic Syndrome-Clinical Research & Reviews

Clinical, Hormonal, and Neuroradiological Characteristics and Therapeutic Outcomes of Prolactinomas in Children and Adolescents at a Single Center

(2020) Aram Yang et al.   Frontiers in Endocrinology

Predictors of Chronic LH-Testosterone Axis Suppression in Male Macroprolactinomas With Normoprolactinemia on Cabergoline

(2020) Manjeetkaur Sehemby et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Impaired hypothalamic leptin sensitivity in pseudopregnant rats treated with chronic prolactin to mimic pregnancy

(2019) Rachael A. Augustine et al.   JOURNAL OF NEUROENDOCRINOLOGY

MANAGEMENT AND OUTCOMES OF GIANT PROLACTINOMA: A SERIES OF 71 PATIENTS

(2019) Oksana Hamidi et al.   Endocrine Practice

The epidemiology, diagnosis and treatment of Prolactinomas:The old and the new

(2019) Philippe Chanson et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Giant Prolactinomas: Outcomes of Multimodal Treatments for 42 Cases with Long-Term Follow-Up

(2018) Liang Lv et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Giant Prolactinomas

(2018) Ilan Shimon   NEUROENDOCRINOLOGY

Pituitary Apoplexy

(2015) Claire Briet et al.   ENDOCRINE REVIEWS

Macroprolactinomas in Children and Adolescents: Factors Associated With the Response to Treatment in 77 Patients

(2015) Sylvie Salenave et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

New insights in prolactin: pathological implications

(2015) Valérie Bernard et al.   Nature Reviews Endocrinology

Gender differences in macroprolactinomas: a single centre experience

(2015) Shruti Khare et al.   Endocrine Connections

THERAPY OF ENDOCRINE DISEASE: The challenges in managing giant prolactinomas

(2014) Dominique Maiter et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Diagnosis and management of hyperprolactinemia: Results of a Brazilian multicenter study with 1234 patients

(2014) L. Vilar et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Giant prolactinomas: the therapeutic approach

(2013) Aline B. Moraes et al.   CLINICAL ENDOCRINOLOGY

Giant prolactinomas in women

(2013) Etienne Delgrange et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients

(2012) Laurent Vroonen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

(2011) Shlomo Melmed et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

(2010) Adrian F. Daly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prolactinomas

(2010) Anne Klibanski   NEW ENGLAND JOURNAL OF MEDICINE

Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients

(2009) Etienne Delgrange et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY